Clinical Drug Experience Knowledgebase

Coronary Artery Disease (approved 2005)

Epilepsy (approved 2005)

Neoplasms (approved 2005)

Ventricular Dysfunction, Left (approved 2005)

Adenocarcinoma (Phase 2)

Adrenal Gland Neoplasms (Phase 3)

Alcohol Drinking (Phase 2/Phase 3)

Alcohol-Induced Disorders (Phase 2/Phase 3)

Alzheimer Disease (Phase 4)

Anus Neoplasms (Phase 2)

Aortic Aneurysm, Abdominal (Phase 4)

Aphasia (Phase 1)

Aphasia, Primary Progressive (Phase 1)

Arteries (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Asthma (Phase 4)

Astrocytoma (Phase 2)

Atherosclerosis (Phase 2)

Autoimmune Diseases (Phase 1)

Brain Neoplasms (Phase 1/Phase 2)

Breast Neoplasms (Phase 4)

Breast Neoplasms, Male (Phase 1/Phase 2)

Carcinoma, Adenoid Cystic (Phase 1/Phase 2)

Carcinoma, Basal Cell (Phase 1/Phase 2)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Mucoepidermoid (Phase 1/Phase 2)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Carcinoma, Verrucous (Phase 1)

Cardiovascular Diseases (Early Phase 1)

Carotid Stenosis (Phase 4)

Chordoma (Phase 1/Phase 2)

Chronic Pain (Phase 1)

Cigarette Smoking (Phase 2)

Cognitive Dysfunction (Phase 2)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 2)

Craniopharyngioma (Phase 2)

Crohn Disease (Phase 4)

Cushing Syndrome (Phase 1/Phase 2)

Cystic Fibrosis (Phase 3)

Dementia, Vascular (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Diagnostic Imaging (Phase 2)

Diagnostic Techniques and Procedures (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Endocrine System Diseases (Phase 1/Phase 2)

Endometrial Neoplasms (Phase 1/Phase 2)

Ependymoma (Phase 2)

Epidermal Growth Factor (Phase 2)

Esophageal Neoplasms (Phase 2/Phase 3)

Frontotemporal Dementia (Phase 4)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Gliosarcoma (Phase 1/Phase 2)

Granuloma (Phase 1/Phase 2)

Hamartoma Syndrome, Multiple (Phase 2)

Head and Neck Neoplasms (Phase 3)

Healthy Volunteers (Phase 1/Phase 2)

Heart Diseases (Phase 4)

Histiocytosis (Phase 3)

Hodgkin Disease (Phase 2)

Hyperparathyroidism, Primary (Phase 2)

Hypersensitivity (Phase 1)

Hypertension, Pulmonary (Phase 2)

Hypertrophy, Left Ventricular (Phase 2)

Hypopharyngeal Neoplasms (Phase 1/Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 1)

Iliac Artery (Phase 1)

Inflammatory Breast Neoplasms (Early Phase 1)

Intermittent Claudication (Phase 1)

Ischemic Attack, Transient (Phase 4)

Joint Prosthesis (Phase 2)

Kidney Neoplasms (Phase 2)

Laryngeal Neoplasms (Phase 1/Phase 2)

Leukemia, Myeloid, Acute (Phase 1)

Lewy Body Disease (Phase 4)

Liver Diseases (Phase 3)

Liver Neoplasms (Phase 2)

Lung Diseases (Phase 2)

Lung Neoplasms (Phase 4)

Lymphoma (Phase 3)

Lymphoma, B-Cell, Marginal Zone (Phase 3)

Lymphoma, Follicular (Phase 2)

Lymphoma, Mantle-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 1)

Mass Screening (Phase 2)

Medulloblastoma (Phase 2)

Melanoma (Phase 2)

Monoclonal Gammopathy of Undetermined Significance (Phase 2)

Mouth Neoplasms (Phase 1/Phase 2)

Multiple Myeloma (Phase 3)

Multiple Pulmonary Nodules (Phase 2)

Multiple Sclerosis (Phase 4)

Mutation (Phase 2)

Mycosis Fungoides (Phase 1)

Myocardial Infarction (Early Phase 1)

Myocardial Ischemia (Phase 4)

Myofascial Pain Syndromes (Early Phase 1)

Nasopharyngeal Carcinoma (Phase 1/Phase 2)

Nasopharyngeal Neoplasms (Phase 1/Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 4)

Neovascularization, Pathologic (Phase 1)

Neuroblastoma (Phase 1/Phase 2)

Neuroendocrine Tumors (Phase 2)

Neuroimaging (Phase 4)

Oligodendroglioma (Phase 2)

Oropharyngeal Neoplasms (Phase 1/Phase 2)

Ovarian Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 2)

Papilloma, Inverted (Phase 1/Phase 2)

Paraganglioma (Phase 2)

Parkinson Disease (Phase 2)

Peripheral Arterial Disease (Phase 1)

Persistent Vegetative State (Early Phase 1)

Pheochromocytoma (Phase 2)

Physiology (Early Phase 1)

Pituitary Neoplasms (Phase 1)

Pleural Effusion, Malignant (Phase 2)

Positron-Emission Tomography (Early Phase 1)

Primary Progressive Nonfluent Aphasia (Phase 1)

Prostatic Neoplasms (Phase 2)

Prostatic Neoplasms, Castration-Resistant (Phase 2)

Pulmonary Embolism (Phase 2)

Pulmonary Fibrosis (Phase 1)

Rectal Neoplasms (Phase 2)

Rhabdoid Tumor (Phase 1/Phase 2)

Salivary Gland Neoplasms (Phase 1/Phase 2)

Sarcoidosis (Phase 2)

Sarcoma (Phase 2)

Sepsis (Phase 3)

Small Cell Lung Carcinoma (Phase 3)

Smoldering Multiple Myeloma (Phase 2)

Solitary Pulmonary Nodule (Phase 2)

Speech Disorders (Phase 1)

Spinal Cord Neoplasms (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 2)

Stroke (Phase 4)

Temporomandibular Joint (Phase 2)

Thyroid Carcinoma, Anaplastic (Phase 2)

Thyroid Neoplasms (Phase 2)

Tobacco (Phase 2)

Tomography (Phase 4)

Tongue Neoplasms (Phase 1/Phase 2)

Tuberculosis (Phase 1/Phase 2)

Tuberculosis, Pulmonary (Phase 1)

Tumor Suppressor Protein p53 (Phase 2)

Urethral Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2/Phase 3)

Vaginal Neoplasms (Phase 2)

Vascular Calcification (Phase 1)

Venous Thromboembolism (Phase 2)

Venous Thrombosis (Phase 2)

von Hippel-Lindau Disease (Phase 2)

Vulvar Neoplasms (Phase 2)

Whole Body Imaging (Phase 4)